Margaret Glavin
Margaret Glavin
agency allowing believe danger disease firm health increasing practices present provide public reason revealed risk serious widespread
FDA's investigation of BTS revealed serious and widespread deficiencies in their manufacturing practices that provide the agency reason to believe that allowing the firm to manufacture would present a danger to public health by increasing the risk of communicable disease transmission.